Ocumetics Technology Corp: MDA EN
Ocumetics Technology Corp: AUDITED ANNUAL FINANCIAL STATEMENTS EN
Ocumetics Announces Completion of Unit Private Placement
Ocumetics Announces December 20, 2023 Webinar Regarding Successful Completion of Animal Study
Ocumetics Announces Successful Completion of Animal Study Q1 2024 First in Human Study Planned
Ocumetics Continues to Meet Significant Development Milestones; Lens Design Optimized for Upcomin...
Ocumetics Welcomes Dr. Doyle Stulting and Dr. Bart McRoberts to Board of Directors
Ocumetics Technology Corp: INTERIM MDA EN
Ocumetics Technology Corp: INTERIM FINANCIAL STATEMENTSREPORT EN
Ocumetics Technology Corp: AB FORM 13-501F1 (CLASS 1 AND 3B REPORTING ISSUERS - PARTICIPATION FEE)
Ocumetics Technology Corp: AUDITED ANNUAL FINANCIAL STATEMENTS - ENGLISH
Ocumetics Technology Corp: FINANCIAL STATEMENTS OF RTO ACQUIRER
Ocumetics Technology Corp: INTERIM FINANCIAL STATEMENTS/REPORT - ENGLISH
Ocumetics Technology Corp: MD&A - ENGLISH
No Data